Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.

Personalized medicine - 1 Jun 2026

Mariki Aliakbar, Mousavi Seyed Mohammad, Kohlmeier Kristi Anne, Kamali Hoda, Shabani Mohammad

Abstract excerpt

Multiple sclerosis (MS) is a complex neurological disorder with inflammation, demyelination, and neurodegeneration in the CNS. Disease-modifying therapies (DMTs) exist, but their efficacy is limited by MS's varied nature, highlighting the need for personalized treatments. From January 2009 to March 2025, a literature search across PubMed, Scopus, Web of Science, and Google Scholar identified over 200 multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to FOXP3 gene

Share to Genetic Predisposition to Disease

Share to HLA-DRB1 Chains

Share to Multiple Sclerosis

Share to Precision Medicine

Source

Identifiers

PMID: 42233619
DOI: 10.1080/17410541.2026.2678216

Genes

CHI3L1
FOXP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.PMID 42233619Read ↗

Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patientsSemantic proximity Read ↗

Epigenetic research in multiple sclerosis: progress, challenges, and opportunitiesSemantic proximity Read ↗

DNA methylation signatures of Multiple Sclerosis occur independently of genetic risk and are primarily attributed to B cells and monocytesSemantic proximity Read ↗

Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.Semantic proximity Read ↗

Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved QuestionsSemantic proximity Read ↗

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosisSemantic proximity Read ↗

Epigenetic Modifications and Therapy in Multiple Sclerosis.Semantic proximity Read ↗

Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatmentSemantic proximity Read ↗

The genetics of multiple sclerosis: an up-to-date review.Semantic proximity Read ↗

Integrated determinants of multiple sclerosis susceptibility: Genetics, environment, infection and the microbiota.Semantic proximity Read ↗

Identification of HLA-DQA1 and HLA-DRB5 as Risk Factors for Multiple Sclerosis: An Epigenome-Wide Methylation Haplotype Association Analysis.Semantic proximity Read ↗

Decoding the molecular and cellular aspects of multiple sclerosis: From diagnosis to therapeutic strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.